Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
肯恩流行病学转变期间对疟疾的自然获得免疫力
基本信息
- 批准号:8486389
- 负责人:
- 金额:$ 61.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAffectAfricaAfrica South of the SaharaAfricanAgeAllelesAntibodiesAntibody FormationAntigensB-LymphocytesBindingBloodC-terminalCellular biologyChildChildhoodClinicalClinical TrialsCohort StudiesConduct Clinical TrialsDevelopmentDiseaseEnzyme-Linked Immunosorbent AssayEpidemiologyEpitopesErythrocytesExposure toFrequenciesFundingGenomicsGoalsGrowthHomologous ProteinImmuneImmunityImmunoglobulin GInsecticidesInterferonsInterleukin-10InterventionKenyaLifeLigandsMaintenanceMalariaMeasurableMeasuresMemoryMemory B-LymphocyteMerozoite Surface Protein 1Morbidity - disease rateOrthologous GeneOutcomes ResearchParasitemiaParasitesPhase III Clinical TrialsPhenotypePlasmaPlasmodium falciparumPredictive ValuePredispositionPrevalenceProteinsPublic HealthRelative (related person)ResearchReticulocytesRiskRoleRuptureSerineStagingSurfaceT cell responseT memory cellT-LymphocyteTertiary Protein StructureTimeTransgenic OrganismsVaccinesWorkacquired immunityage relatedantigen bindingapical membraneasexualbasecircumsporozoite proteincohortcytokinedensitydesigninsightmemory CD4 T lymphocytenovelresponsetransmission processvaccine candidatevaccine developmentvector
项目摘要
DESCRIPTION (provided by applicant): The long term goals of the proposed work are to understand how anti-malaria antibodies and T-cell and B-cell memory contribute to protection against asexual blood stage Plasmodium falciparum and the impact of vector interventions that are now decreasing malaria transmission in Africa on immune memory and malaria susceptibility. Our previous research in western Kenya has been concerned with elucidating the mechanisms underlying age-related naturally acquired immunity, with a focus on antibody and T-cell responses to the 42 kDa C-terminal region of Merozoite Surface Protein 1. This earlier work was done when malaria transmission was higher than at present and before a clinical trial of MSP1 in Kenyan children showed no efficacy. Accordingly, our research strategy has been modified to address the impact of reduced malaria exposure on acquired immunity and stalled progress toward development of a blood stage vaccine. The Specific Aims are to: 1: Identify a repertoire of merozoite invasion ligands important in protection against parasitemia and clinical malaria. Antibodies from well characterized historic cohorts of children and adults (2000-09) will be used to identify merozoite proteins credentialed as biologically significant by their established role for progression of merozoites through the erythrocyte cycle (MSP1, AMA1, EBA175, EBA140, Reticulocyte-binding homolog (Rh) proteins, SERA5) and other targets that are (presently) not well characterized (6-cys proteins, MSP6, MSP7). 2: Examine how T-cell memory to credentialed merozoite antigens contributes to age-related malaria immunity. CD4 T-cell memory subsets and cytokines implicated to have a protective role (IFN-() and counter- regulatory function on IFN-( (IL-10, TGF-¿) from historic and new (2012-14) child and adult cohorts will be evaluated and compared. 3: Evaluate the relationship of B-cell memory to the development and maintenance of acquired immunity. The frequency of circulating Ag-specific memory B-cells will be quantified and correlated with the magnitude and durability of antibody responses, incident parasitemia, and clinical malaria. These responses will be evaluated in the context of B-cell memory phenotypes stratified according to age and clinical malaria status. Measurable outcomes from this research will identify and validate new malaria antigens as vaccine candidates and contribute to understanding the mechanisms and impact of decreasing transmission on the age profile and durability of naturally acquired immunity against malaria.
描述(申请人提供):拟议工作的长期目标是了解抗疟疾抗体和T细胞和B细胞记忆如何有助于预防无性血液期恶性疟原虫,以及媒介干预措施对免疫记忆和疟疾易感性的影响目前正在减少非洲的疟疾传播。我们之前在肯尼亚西部的研究一直致力于阐明与年龄相关的自然获得性免疫的机制,重点是针对裂殖子表面蛋白1 42 kDa C末端区域的抗体和T细胞反应。这项早期工作是在疟疾传播比目前更高的时候完成的,在肯尼亚儿童中进行的MSP1临床试验显示无效之前。因此,我们的研究战略已经修改,以解决疟疾暴露减少对获得性免疫的影响,以及血液期疫苗开发的停滞进展。具体目标是:1:确定在预防寄生虫血症和临床疟疾方面重要的裂殖子入侵配体的保留体系。来自具有良好特征的儿童和成人历史队列(2000-09年)的抗体将被用于鉴定裂殖子蛋白(MSP1、AMA1、EBA175、EBA140、网织红细胞结合同源物(Rh)蛋白、SERA5)和其他(目前)不具良好特征的靶标(6-CyS蛋白、MSP6、MSP7),这些蛋白被证明具有生物学意义,因为它们在红细胞周期中对裂殖子的进展起到了作用。2:研究T细胞对获得证书的裂殖子抗原的记忆如何有助于年龄相关的疟疾免疫。将评估和比较历史和新的(2012-14)儿童和成人队列中的CD4T细胞记忆亚群和细胞因子对干扰素-(IL-10,转化生长因子-β)的保护作用和反向调节功能。3:探讨B细胞记忆与获得性免疫发生和维持的关系。循环中的抗原特异性记忆B细胞的频率将被量化,并与抗体反应的大小和持久性、发生的寄生虫血症和临床疟疾相关。这些反应将在根据年龄和临床疟疾状况分层的B细胞记忆表型的背景下进行评估。这项研究的可衡量结果将确定和验证新的疟疾抗原作为候选疫苗,并有助于理解减少传播对年龄分布和自然获得的疟疾免疫持久性的影响的机制和影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Walter Kazura其他文献
James Walter Kazura的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Walter Kazura', 18)}}的其他基金
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria
环境改造对恶性疟原虫和间日疟原虫疟疾发病机制和免疫的影响
- 批准号:
10608071 - 财政年份:2017
- 资助金额:
$ 61.4万 - 项目类别:
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria
环境改造对恶性疟原虫和间日疟原虫疟疾发病机制和免疫的影响
- 批准号:
10382276 - 财政年份:2017
- 资助金额:
$ 61.4万 - 项目类别:
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria
Kruppel 样因子 2 可对抗儿童脑型疟疾的血管和免疫功能障碍
- 批准号:
10084256 - 财政年份:2017
- 资助金额:
$ 61.4万 - 项目类别:
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
肯恩流行病学转变期间对疟疾的自然获得免疫力
- 批准号:
8289398 - 财政年份:2011
- 资助金额:
$ 61.4万 - 项目类别:
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
肯恩流行病学转变期间对疟疾的自然获得免疫力
- 批准号:
8690756 - 财政年份:2011
- 资助金额:
$ 61.4万 - 项目类别:
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
肯恩流行病学转变期间对疟疾的自然获得免疫力
- 批准号:
8146459 - 财政年份:2011
- 资助金额:
$ 61.4万 - 项目类别:
Innate immune factor in host susceptibility to rift valley fever virus
宿主对裂谷热病毒易感性的先天免疫因素
- 批准号:
8234941 - 财政年份:2011
- 资助金额:
$ 61.4万 - 项目类别:
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
肯恩流行病学转变期间对疟疾的自然获得免疫力
- 批准号:
8865541 - 财政年份:2011
- 资助金额:
$ 61.4万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 61.4万 - 项目类别:
Research Grant